• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个关于替马西泮对睡眠影响的药效学马尔可夫混合效应模型。

A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep.

作者信息

Karlsson M O, Schoemaker R C, Kemp B, Cohen A F, van Gerven J M, Tuk B, Peck C C, Danhof M

机构信息

Department of Pharmacy, Uppsala University, Sweden.

出版信息

Clin Pharmacol Ther. 2000 Aug;68(2):175-88. doi: 10.1067/mcp.2000.108669.

DOI:10.1067/mcp.2000.108669
PMID:10976549
Abstract

BACKGROUND

A hypnogram shows how sleep travels through its various stages in the course of a night. The sleep stage changes can be quantified to study sedative drug effects.

METHODS

Hypnograms from 21 patients with primary insomnia were collected during a randomized, placebo-controlled crossover study of 20 mg temazepam. A separate daytime session was performed to determine the pharmacokinetics of 20 mg temazepam and its effect on saccadic eye movement and electroencephalogram. A first-order Markov model was developed to describe the probability of sleep stage changes as a function of time after drug intake and time after last sleep stage change. The influence of temazepam concentration on the probability to change sleep stage was incorporated into the model.

RESULTS

Transitions between sleep stages were profoundly influenced by the time of the night and by the time since the last change of sleep stage. Temazepam reduced the time spent awake. This effect could be attributed to four mechanisms: (1) transition to "deeper" sleep was facilitated, (2) transition to "lighter" sleep was inhibited, (3) regardless of sleep stage, the transition to wake state was inhibited, and (4) return to sleep was facilitated. Daytime sensitivities to temazepam, measured with the surrogate markers saccadic peak velocity and electroencephalogram beta activity, each correlated with one of the transition probabilities influenced by temazepam.

CONCLUSIONS

By the development of a Markov model for these non-ordered six categorical data, the effect of temazepam on the sleep-wake status could be interpreted in terms of known mechanisms for sleep generation and benzodiazepine pharmacology.

摘要

背景

睡眠图展示了睡眠在一夜之中如何历经各个阶段。睡眠阶段的变化可进行量化,以研究镇静药物的效果。

方法

在一项关于20毫克替马西泮的随机、安慰剂对照交叉研究中,收集了21名原发性失眠患者的睡眠图。还进行了一个单独的白天时段研究,以确定20毫克替马西泮的药代动力学及其对眼球快速运动和脑电图的影响。建立了一个一阶马尔可夫模型,以描述睡眠阶段变化的概率是药物摄入后时间和上次睡眠阶段变化后时间的函数。替马西泮浓度对睡眠阶段变化概率的影响被纳入该模型。

结果

睡眠阶段之间的转换受到夜间时间和自上次睡眠阶段变化以来的时间的深刻影响。替马西泮减少了清醒时间。这种效果可归因于四种机制:(1)促进向“更深”睡眠的转换,(2)抑制向“更浅”睡眠的转换,(3)无论睡眠阶段如何,抑制向清醒状态的转换,以及(4)促进恢复睡眠。用替代指标眼球快速运动峰值速度和脑电图β活动测量的白天对替马西泮的敏感性,分别与受替马西泮影响的一种转换概率相关。

结论

通过为这些无序的六分类数据建立马尔可夫模型,替马西泮对睡眠-觉醒状态的影响可以根据已知的睡眠产生机制和苯二氮䓬药理学来解释。

相似文献

1
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep.一个关于替马西泮对睡眠影响的药效学马尔可夫混合效应模型。
Clin Pharmacol Ther. 2000 Aug;68(2):175-88. doi: 10.1067/mcp.2000.108669.
2
Pharmacodynamics of temazepam in primary insomnia: assessment of the value of quantitative electroencephalography and saccadic eye movements in predicting improvement of sleep.替马西泮治疗原发性失眠的药效学:定量脑电图和眼球快速运动在预测睡眠改善方面的价值评估
Clin Pharmacol Ther. 1997 Oct;62(4):444-52. doi: 10.1016/S0009-9236(97)90123-5.
3
Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia.在短暂性失眠模型中,7.5毫克和15毫克替马西泮对睡眠维持和睡眠结构的影响。
Curr Med Res Opin. 2005 Feb;21(2):223-30. doi: 10.1185/030079905X25541.
4
Dose effects of temazepam in transient insomnia.替马西泮对短暂性失眠的剂量效应。
Arzneimittelforschung. 1990 Aug;40(8):859-62.
5
Dose effects of temazepam tablets on sleep.替马西泮片对睡眠的剂量效应。
Drugs Exp Clin Res. 1986;12(8):693-9.
6
Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.唑吡坦在反弹性失眠方面并不优于替马西泮:一项对照研究。
Eur Neuropsychopharmacol. 2004 Aug;14(4):301-6. doi: 10.1016/j.euroneuro.2003.09.007.
7
Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.唑吡坦对失眠患者睡眠结构及其次晨残留效应的影响:与溴替唑仑的随机交叉对照研究
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):22-9. doi: 10.1016/j.pnpbp.2005.06.018. Epub 2005 Jul 25.
8
Acutely shifting the sleep-wake cycle: nighttime sleepiness after diurnal administration of temazepam or placebo.急性改变睡眠-觉醒周期:日间服用替马西泮或安慰剂后的夜间嗜睡。
Aviat Space Environ Med. 1997 Aug;68(8):688-94.
9
Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial.替马西泮和苯海拉明治疗老年失眠症2周的效果:一项随机、安慰剂对照试验。
J Clin Psychopharmacol. 2008 Apr;28(2):182-8. doi: 10.1097/JCP.0b013e31816a9e4f.
10
Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.三甲丙咪嗪治疗原发性失眠:一项多导睡眠图双盲对照研究的结果
Pharmacopsychiatry. 2002 Sep;35(5):165-74. doi: 10.1055/s-2002-34119.

引用本文的文献

1
Interplay between pharmacokinetics and immunogenicity of therapeutic proteins: stepwise development of a bidirectional joint pharmacokinetics-anti-drug antibodies model.治疗性蛋白质的药代动力学与免疫原性之间的相互作用:双向联合药代动力学-抗药物抗体模型的逐步发展
J Pharmacokinet Pharmacodyn. 2025 May 21;52(3):33. doi: 10.1007/s10928-025-09971-w.
2
A tutorial on pharmacometric Markov models.药物计量马尔可夫模型教程。
CPT Pharmacometrics Syst Pharmacol. 2025 Feb;14(2):197-216. doi: 10.1002/psp4.13278. Epub 2024 Dec 13.
3
Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approach.
采用马尔可夫模型方法对科塔度肽引起恶心发生率的暴露-反应关系进行建模。
CPT Pharmacometrics Syst Pharmacol. 2024 Sep;13(9):1582-1594. doi: 10.1002/psp4.13194. Epub 2024 Jul 23.
4
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab.基于模拟的抗 FGFR/klb 双特异性抗体 fazpilodemab 个体化给药方案的评价。
CPT Pharmacometrics Syst Pharmacol. 2024 Apr;13(4):544-550. doi: 10.1002/psp4.13111. Epub 2024 Feb 11.
5
A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development.肿瘤临床药物开发中建模和模拟实践的全面监管和行业审查。
J Pharmacokinet Pharmacodyn. 2023 Jun;50(3):147-172. doi: 10.1007/s10928-023-09850-2. Epub 2023 Mar 4.
6
Rituximab pharmacokinetic and pharmacokinetic-pharmacodynamic evaluation based on a study in diffuse large B-cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarity.基于弥漫性大 B 细胞淋巴瘤研究的利妥昔单抗药代动力学和药代动力学-药效学评价:肿瘤大小对药代动力学的影响及药代动力学相似性评价。
CPT Pharmacometrics Syst Pharmacol. 2023 Feb;12(2):154-167. doi: 10.1002/psp4.12885. Epub 2022 Dec 25.
7
Pharmacotherapeutic management of insomnia and effects on sleep processes, neural plasticity, and brain systems modulating stress: A narrative review.失眠的药物治疗管理及其对睡眠过程、神经可塑性和调节应激的脑系统的影响:一项叙述性综述。
Front Neurosci. 2022 Jul 29;16:893015. doi: 10.3389/fnins.2022.893015. eCollection 2022.
8
Semimechanistic models to relate noxious stimulation, movement, and pupillary dilation responses in the presence of opioids.在阿片类药物存在的情况下,将有害刺激、运动和瞳孔扩张反应联系起来的半机械模型。
CPT Pharmacometrics Syst Pharmacol. 2022 May;11(5):581-593. doi: 10.1002/psp4.12729. Epub 2021 Nov 18.
9
Multistate model for pharmacometric analyses of overall survival in HER2-negative breast cancer patients treated with docetaxel.多州模型用于分析 HER2 阴性乳腺癌患者接受多西紫杉醇治疗的总生存期的药代动力学分析。
CPT Pharmacometrics Syst Pharmacol. 2021 Oct;10(10):1255-1266. doi: 10.1002/psp4.12693. Epub 2021 Aug 3.
10
Evaluation of patient-reported severity of hand-foot syndrome under capecitabine using a Markov modeling approach.采用 Markov 建模方法评估卡培他滨所致手足综合征患者报告的严重程度。
Cancer Chemother Pharmacol. 2020 Sep;86(3):435-444. doi: 10.1007/s00280-020-04128-7. Epub 2020 Aug 27.